American Journal of Ophthalmology Case Reports (Jun 2022)

Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use

  • Joseph B. Alsberge,
  • Daniel Y. Lee,
  • J. Michael Jumper

Journal volume & issue
Vol. 26
p. 101482

Abstract

Read online

Purpose: To report a case of central serous chorioretinopathy (CSC) associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use. Observations: A 34-year-old man presented for evaluation of a “cloud” in his vision for three months. He was taking Adderall for attention deficit hyperactivity disorder and mometasone 0.1% topical cream for eczema. He was found to have subretinal fluid in the left eye consistent with CSC. The subretinal fluid persisted despite cessation of the steroid cream but resolved after cessation of the Adderall. The subretinal fluid returned when the patient restarted Adderall and again resolved after he stopped it for a second time. Conclusions: Though we cannot prove causality, the course of events was suggestive of a direct relationship between Adderall use and CSC in this patient, with exogenous steroid as a possible modifying factor.

Keywords